Brave Asset Management »

Achilles Therapeutics shares owned by Brave Asset Management

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Brave Asset Management from 13F filings

Historical chart of Brave Asset Management investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Brave Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Brave Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $13k 10k 1.25

More positions owned by Brave Asset Management

Ishares Tr Core Us Aggbd Et (AGG)
Select Sector Spdr Tr Technology (XLK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Eafe Value Etf (EFV)
J Global (ZD)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Walt Disney Company (DIS)
Select Sector Spdr Tr Sbi Cons Discr (XLY)

View all positions for Brave Asset Management

Top funds holding Achilles Therapeutics

Syncona Portfolio
Fcpm Iii Services B.v.
Redmile Group
Ikarian Capital
Baker Bros. Advisors
Artal Group
Boothbay Fund Management
Acadian Asset Management
Citadel Advisors
Forefront Analytics
Virtu Financial
Hrt Financial
Geode Capital Management
Millennium Management
Vontobel Holding

View all funds holding Achilles Therapeutics